Literature DB >> 10750939

Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline.

S T Dorsey, L A Biblo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10750939     DOI： 10.1016/s0735-6757(00)90027-5

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  10 in total

Review 1.  Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest.

Authors:  Serge Sicouri; Charles Antzelevitch
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

Review 2.  QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.

Authors:  Katharina Wenzel-Seifert; Markus Wittmann; Ekkehard Haen
Journal:  Dtsch Arztebl Int       Date:  2011-10-14       Impact factor: 5.594

3.  Blockade of HERG cardiac K+ current by antifungal drug miconazole.

Authors:  Kan Kikuchi; Toshihisa Nagatomo; Haruhiko Abe; Kazunobu Kawakami; Henry J Duff; Jonathan C Makielski; Craig T January; Yasuhide Nakashima
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

4.  Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.

Authors:  Weerawat Manosuthi; Somnuek Sungkanuparph; Thanomsak Anekthananon; Khuanchai Supparatpinyo; Tracy L Nolen; Louise O Zimmer; Peter G Pappas; Robert A Larsen; Scott G Filler; Ploenchan Chetchotisakd
Journal:  Int J Antimicrob Agents       Date:  2009-06-30       Impact factor: 5.283

Review 5.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Sudden cardiac death secondary to antidepressant and antipsychotic drugs.

Authors:  Serge Sicouri; Charles Antzelevitch
Journal:  Expert Opin Drug Saf       Date:  2008-03       Impact factor: 4.250

7.  Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole.

Authors:  Jesse J Esch; Michal J Kantoch
Journal:  Pediatr Cardiol       Date:  2007-09-12       Impact factor: 1.655

8.  Clinical use of antidepressant therapy and associated cardiovascular risk.

Authors:  W Stephen Waring
Journal:  Drug Healthc Patient Saf       Date:  2012-08-17

9.  QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization.

Authors:  J Keirns; A Desai; D Kowalski; C Lademacher; S Mujais; B Parker; M J Schneidkraut; R Townsend; T Wojtkowski; T Yamazaki; M Yen; P R Kowey
Journal:  Clin Pharmacol Ther       Date:  2017-02-13       Impact factor: 6.875

10.  Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals.

Authors:  Zofia Tylutki; Aleksander Mendyk; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-06-25       Impact factor: 2.745
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.